Jeffrey Jones

Technik-/Wissenschafts-/F&E-Leiter bei CULLINAN THERAPEUTICS, INC.

Vermögen: 321 739 $ am 31.05.2024

53 Jahre

Consumer Services

Health Technology

Finance

Aktive Positionen von Jeffrey Jones

Unternehmen	Position	Beginn	Ende
CULLINAN THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	28.02.2022	-

Unternehmen	Position	Beginn	Ende
BRISTOL-MYERS SQUIBB COMPANY	Technik-/Wissenschafts-/F&E-Leiter	01.08.2017	01.04.2020
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01.04.2020	01.02.2022
The Ohio State University College of Medicine	Corporate Officer/Principal	-	-
Cullinan Oncology LLC Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.	Technik-/Wissenschafts-/F&E-Leiter	01.02.2022	-

University of Michigan Medical School	Doctorate Degree
Fisher College of Business	Masters Business Admin
The University of Texas Health Science Center at Houston	Graduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
CULLINAN THERAPEUTICS, INC.	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private Unternehmen	1
Cullinan Oncology LLC Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.	Finance